Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 369
Filtrar
2.
Org Lett ; 23(17): 6967-6971, 2021 09 03.
Artículo en Inglés | MEDLINE | ID: mdl-34388000

RESUMEN

A cryptic trans-acyltransferase polyketide synthase biosynthetic gene cluster sdl (80 kb) from Streptomyces sp. B59 was cloned and transferred into a heterologous host Streptomyces albus J1074, resulting in a class of polycyclic macrolide shuangdaolides A-D (1-4) and dumulmycin (5). Heterologous expression and gene inactivation experiments allowed the identification of two biosynthetic intermediates, 6 and 7, suggesting an unusual multidomain SDR oxidoreductase SdlR in charge of the formation of a rare 2-hydroxycyclopentenone moiety in this class of compounds.


Asunto(s)
Antibacterianos/biosíntesis , Macrólidos/química , Sintasas Poliquetidas/química , Inhibidores de la Síntesis de la Proteína/química , Streptomyces/química , Antibacterianos/química , Macrólidos/metabolismo , Estructura Molecular , Familia de Multigenes , Sintasas Poliquetidas/metabolismo , Inhibidores de la Síntesis de la Proteína/metabolismo
3.
Cells ; 10(7)2021 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-34359954

RESUMEN

It has been demonstrated that inhibiting Notch signaling through γ-secretase inhibitor (GSI) treatment increases myogenesis, AKT/mTOR signaling, and muscle protein synthesis (MPS) in C2C12 myotubes. The purpose of this study was to determine if GSI-mediated effects on myogenesis and MPS are dependent on AKT/mTOR signaling. C2C12 cells were assessed for indices of myotube formation, anabolic signaling, and MPS following GSI treatment in combination with rapamycin and API-1, inhibitors of mTOR and AKT, respectively. GSI treatment increased several indices of myotube fusion and MPS in C2C12 myotubes. GSI-mediated effects on myotube formation and fusion were completely negated by treatment with rapamycin and API-1. Meanwhile, GSI treatment was able to rescue MPS in C2C12 myotubes exposed to rapamycin or rapamycin combined with API-1. Examination of protein expression revealed that GSI treatment was able to rescue pGSK3ß Ser9 despite AKT inhibition by API-1. These findings demonstrate that GSI treatment is able to rescue MPS independent of AKT/mTOR signaling, possibly via GSK3ß modulation.


Asunto(s)
Secretasas de la Proteína Precursora del Amiloide/efectos de los fármacos , Fibras Musculares Esqueléticas/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/farmacología , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Ratones , Fibras Musculares Esqueléticas/metabolismo , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Mioblastos/efectos de los fármacos , Mioblastos/metabolismo , Inhibidores de la Síntesis de la Proteína/metabolismo , Transducción de Señal/efectos de los fármacos
4.
J Mol Biol ; 433(10): 166942, 2021 05 14.
Artículo en Inglés | MEDLINE | ID: mdl-33744313

RESUMEN

Macrolide antibiotics, such as erythromycin, bind to the nascent peptide exit tunnel (NPET) of the bacterial ribosome and modulate protein synthesis depending on the nascent peptide sequence. Whereas in vitro biochemical and structural methods have been instrumental in dissecting and explaining the molecular details of macrolide-induced peptidyl-tRNA drop-off and ribosome stalling, the dynamic effects of the drugs on ongoing protein synthesis inside live bacterial cells are far less explored. In the present study, we used single-particle tracking of dye-labeled tRNAs to study the kinetics of mRNA translation in the presence of erythromycin, directly inside live Escherichia coli cells. In erythromycin-treated cells, we find that the dwells of elongator tRNAPhe on ribosomes extend significantly, but they occur much more seldom. In contrast, the drug barely affects the ribosome binding events of the initiator tRNAfMet. By overexpressing specific short peptides, we further find context-specific ribosome binding dynamics of tRNAPhe, underscoring the complexity of erythromycin's effect on protein synthesis in bacterial cells.


Asunto(s)
Antibacterianos/farmacología , Eritromicina/farmacología , Escherichia coli/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/farmacología , Ribosomas/efectos de los fármacos , Secuencia de Aminoácidos , Antibacterianos/metabolismo , Carbocianinas/química , Codón , Eritromicina/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Colorantes Fluorescentes/química , Péptidos/química , Péptidos/genética , Péptidos/metabolismo , Unión Proteica , Inhibidores de la Síntesis de la Proteína/metabolismo , ARN Bacteriano/química , ARN Bacteriano/genética , ARN Bacteriano/metabolismo , ARN de Transferencia de Metionina/química , ARN de Transferencia de Metionina/genética , ARN de Transferencia de Metionina/metabolismo , ARN de Transferencia de Fenilalanina/química , ARN de Transferencia de Fenilalanina/genética , ARN de Transferencia de Fenilalanina/metabolismo , Ribosomas/genética , Ribosomas/metabolismo , Ribosomas/ultraestructura , Imagen Individual de Molécula
5.
Biol Cell ; 113(5): 264-269, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33443774

RESUMEN

BACKGROUND INFORMATION: Plants use transporters polarly localised in the plasma membrane for the directional transport of nutrients. The boric acid/borate (B) exporter BOR1 is localised polarly in the inner lateral domain of the plasma membrane in various root cells for efficient translocation of B under B limitation. With a high B supply, BOR1 is ubiquitinated and transported to vacuoles for degradation. The polar localisation and vacuolar targeting of BOR1 are maintained by different endocytosis mechanisms. RESULTS: We demonstrated that one of the most utilised inhibitors in endosomal recycling, brefeldin A (BFA), inhibits the polar localisation of BOR1. BFA inhibits a subset of guanine-nucleotide exchange factors (ARF-GEFs), regulators of vesicle formation. Using a transgenic line expressing BFA-resistant engineered GNOM, we identified GNOM as the key ARF-GEF in endocytosis and maintenance of the polar localisation of BOR1. CONCLUSIONS AND SIGNIFICANCE: We found that BFA inhibits the polar localisation of BOR1 by inhibiting GNOM activity. Our results suggest that GNOM-dependent endocytosis contributes to the maintenance of the polar localisation of BOR1 under B limitation. We propose a model of BOR1 transcytosis initiated from GNOM-dependent endocytosis.


Asunto(s)
Antiportadores/metabolismo , Proteínas de Arabidopsis/metabolismo , Arabidopsis/metabolismo , Membrana Celular/metabolismo , Factores de Intercambio de Guanina Nucleótido/metabolismo , Plantas Modificadas Genéticamente/metabolismo , Brefeldino A/metabolismo , Endocitosis , Inhibidores de la Síntesis de la Proteína/metabolismo
6.
Elife ; 92020 08 26.
Artículo en Inglés | MEDLINE | ID: mdl-32844746

RESUMEN

Puromycin is an amino-acyl transfer RNA analog widely employed in studies of protein synthesis. Since puromycin is covalently incorporated into nascent polypeptide chains, anti-puromycin immunofluorescence enables visualization of nascent protein synthesis. A common assumption in studies of local messenger RNA translation is that the anti-puromycin staining of puromycylated nascent polypeptides in fixed cells accurately reports on their original site of translation, particularly when ribosomes are stalled with elongation inhibitors prior to puromycin treatment. However, when we attempted to implement a proximity ligation assay to detect ribosome-puromycin complexes, we found no evidence to support this assumption. We further demonstrated, using biochemical assays and live cell imaging of nascent polypeptides in mammalian cells, that puromycylated nascent polypeptides rapidly dissociate from ribosomes even in the presence of elongation inhibitors. Our results suggest that attempts to define precise subcellular translation sites using anti-puromycin immunostaining may be confounded by release of puromycylated nascent polypeptide chains prior to fixation.


Asunto(s)
Extensión de la Cadena Peptídica de Translación/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína , Puromicina , Ribosomas , Animales , Línea Celular Tumoral , Ratones , Inhibidores de la Síntesis de la Proteína/metabolismo , Inhibidores de la Síntesis de la Proteína/farmacología , Proteínas/química , Proteínas/metabolismo , Puromicina/metabolismo , Puromicina/farmacología , ARN Mensajero/química , ARN Mensajero/metabolismo , Aminoacil-ARN de Transferencia/química , Aminoacil-ARN de Transferencia/metabolismo , Ribosomas/efectos de los fármacos , Ribosomas/metabolismo
7.
Elife ; 92020 08 26.
Artículo en Inglés | MEDLINE | ID: mdl-32844748

RESUMEN

Puromycin is a tyrosyl-tRNA mimic that blocks translation by labeling and releasing elongating polypeptide chains from translating ribosomes. Puromycin has been used in molecular biology research for decades as a translation inhibitor. The development of puromycin antibodies and derivatized puromycin analogs has enabled the quantification of active translation in bulk and single-cell assays. More recently, in vivo puromycylation assays have become popular tools for localizing translating ribosomes in cells. These assays often use elongation inhibitors to purportedly inhibit the release of puromycin-labeled nascent peptides from ribosomes. Using in vitro and in vivo experiments in various eukaryotic systems, we demonstrate that, even in the presence of elongation inhibitors, puromycylated peptides are released and diffuse away from ribosomes. Puromycylation assays reveal subcellular sites, such as nuclei, where puromycylated peptides accumulate post-release and which do not necessarily coincide with sites of active translation. Our findings urge caution when interpreting puromycylation assays in vivo.


Asunto(s)
Núcleo Celular , Biosíntesis de Proteínas , Inhibidores de la Síntesis de la Proteína , Puromicina , Animales , Caenorhabditis elegans , Núcleo Celular/química , Núcleo Celular/metabolismo , Emetina/metabolismo , Emetina/farmacología , Péptidos/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Biosíntesis de Proteínas/fisiología , Inhibidores de la Síntesis de la Proteína/metabolismo , Inhibidores de la Síntesis de la Proteína/farmacología , Puromicina/metabolismo , Puromicina/farmacología , ARN de Transferencia/metabolismo , Conejos , Ribosomas/metabolismo , Análisis de la Célula Individual
8.
Gene ; 754: 144857, 2020 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-32512159

RESUMEN

Ribosome Inactivating Proteins (RIPs) are RNA N-glycosidases that depurinate a specific adenine residue in the conserved sarcin/ricin loop of the 28S rRNA. The occurrence of RIP genes has been described in a wide range of plant taxa, as well as in several species of bacteria and fungi. A remarkable case is the presence of these genes in metazoans belonging to the Culicinae subfamily. We reported that these genes are derived from a single horizontal gene transfer event, most likely from a bacterial donor species. Moreover, we have shown evidence that mosquito RIP genes are evolving under purifying selection, suggesting that these toxins have acquired a functional role in these organisms. In the present work, we characterized the intra-specific sequence variability of Aedes aegypti RIP genes (RIPAe1, RIPAe2, and RIPAe3) and tested their expression at the mRNA level. Our results show that RIPAe2 and RIPAe3 are transcribed and polyadenylated, and their expression levels are modulated across the developmental stages. Varibility among genes was observed, including the existence of null alleles for RIPAe1 and RIPAe2, with variants showing partial deletions. These results further support the existence of a physiological function for these foreign genes in mosquitoes. The possible nature of this functionality is discussed.


Asunto(s)
Aedes/genética , Inhibidores de la Síntesis de la Proteína/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Ribosomas/metabolismo , Toxinas Biológicas/metabolismo , Aedes/fisiología , Animales , Secuencia de Bases , Proteínas Inactivadoras de Ribosomas/genética , Homología de Secuencia , Toxinas Biológicas/genética
9.
Prog Biophys Mol Biol ; 152: 55-63, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-31738981

RESUMEN

The branched respiratory chain of Mycobacterium tuberculosis has attracted attention as a highly promising target for next-generation antibacterials. This system includes two terminal oxidases of which the exclusively bacterial cytochrome bd represents the less energy-efficient one. Albeit dispensable for growth under standard laboratory conditions, cytochrome bd is important during environmental stress. In this review, we discuss the role of cytochrome bd during infection of the mammalian host and in the defense against antibacterials. Deeper insight into the biochemistry of mycobacterial cytochrome bd is needed to understand the physiological role of this bacteria-specific defense factor. Conversely, cytochrome bd may be utilized to gain information on mycobacterial physiology in vitro and during host infection. Knowledge-based manipulation of cytochrome bd function may assist in designing the next-generation tuberculosis combination chemotherapy.


Asunto(s)
Antibacterianos/metabolismo , Proteínas Bacterianas/metabolismo , Grupo Citocromo b/metabolismo , Complejo IV de Transporte de Electrones/metabolismo , Mycobacterium tuberculosis/efectos de los fármacos , Antituberculosos/metabolismo , Membrana Celular/metabolismo , Descubrimiento de Drogas , Quimioterapia Combinada , Transporte de Electrón/efectos de los fármacos , Humanos , Inhibidores de la Síntesis de la Proteína/metabolismo , Transducción de Señal , Tuberculosis/tratamiento farmacológico
10.
Mol Cell ; 73(4): 738-748.e9, 2019 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-30595437

RESUMEN

A class of translation inhibitors, exemplified by the natural product rocaglamide A (RocA), isolated from Aglaia genus plants, exhibits antitumor activity by clamping eukaryotic translation initiation factor 4A (eIF4A) onto polypurine sequences in mRNAs. This unusual inhibitory mechanism raises the question of how the drug imposes sequence selectivity onto a general translation factor. Here, we determined the crystal structure of the human eIF4A1⋅ATP analog⋅RocA⋅polypurine RNA complex. RocA targets the "bi-molecular cavity" formed characteristically by eIF4A1 and a sharply bent pair of consecutive purines in the RNA. Natural amino acid substitutions found in Aglaia eIF4As changed the cavity shape, leading to RocA resistance. This study provides an example of an RNA-sequence-selective interfacial inhibitor fitting into the space shaped cooperatively by protein and RNA with specific sequences.


Asunto(s)
Benzofuranos/metabolismo , Factor 4A Eucariótico de Iniciación/metabolismo , Biosíntesis de Proteínas , Inhibidores de la Síntesis de la Proteína/metabolismo , ARN/metabolismo , Ribosomas/metabolismo , Adenilil Imidodifosfato/química , Adenilil Imidodifosfato/metabolismo , Aglaia/química , Aglaia/genética , Aglaia/metabolismo , Sustitución de Aminoácidos , Benzofuranos/química , Benzofuranos/aislamiento & purificación , Benzofuranos/farmacología , Sitios de Unión , Resistencia a Medicamentos/genética , Factor 4A Eucariótico de Iniciación/química , Factor 4A Eucariótico de Iniciación/genética , Células HEK293 , Humanos , Modelos Moleculares , Estructura Molecular , Mutación , Proteínas de Plantas/química , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Unión Proteica , Biosíntesis de Proteínas/efectos de los fármacos , Biosíntesis de Proteínas/genética , Dominios y Motivos de Interacción de Proteínas , Inhibidores de la Síntesis de la Proteína/química , Inhibidores de la Síntesis de la Proteína/aislamiento & purificación , Inhibidores de la Síntesis de la Proteína/farmacología , ARN/química , Ribosomas/química , Ribosomas/efectos de los fármacos , Ribosomas/genética , Relación Estructura-Actividad
12.
Elife ; 72018 11 27.
Artículo en Inglés | MEDLINE | ID: mdl-30479271

RESUMEN

Aging impairs the activation of stress signaling pathways (SSPs), preventing the induction of longevity mechanisms late in life. Here, we show that the antibiotic minocycline increases lifespan and reduces protein aggregation even in old, SSP-deficient Caenorhabditis elegans by targeting cytoplasmic ribosomes, preferentially attenuating translation of highly translated mRNAs. In contrast to most other longevity paradigms, minocycline inhibits rather than activates all major SSPs and extends lifespan in mutants deficient in the activation of SSPs, lysosomal or autophagic pathways. We propose that minocycline lowers the concentration of newly synthesized aggregation-prone proteins, resulting in a relative increase in protein-folding capacity without the necessity to induce protein-folding pathways. Our study suggests that in old individuals with incapacitated SSPs or autophagic pathways, pharmacological attenuation of cytoplasmic translation is a promising strategy to reduce protein aggregation. Altogether, it provides a geroprotecive mechanism for the many beneficial effects of tetracyclines in models of neurodegenerative disease. Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/fisiología , Longevidad/efectos de los fármacos , Minociclina/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/metabolismo , Proteostasis/efectos de los fármacos , Animales , Agregación Patológica de Proteínas/prevención & control , Ribosomas/efectos de los fármacos , Ribosomas/metabolismo
13.
Methods Mol Biol ; 1789: 155-165, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29916078

RESUMEN

Eukaryotic cells comprise various organelles surrounded by the membrane. Each organelle is characterized by unique proteins and lipids and has its own specific functions. Single membrane-bounded organelles, including the Golgi apparatus, endosomes, and vacuoles are connected by membrane trafficking. Identifying the organelle localization of a protein of interest is essential for determining the proteins physiological functions. Here, we describe methods for determining protein subcellular localization using the inhibitors brefeldin A and wortmannin in Arabidopsis thaliana.


Asunto(s)
Proteínas de Arabidopsis/análisis , Arabidopsis/metabolismo , Brefeldino A/metabolismo , Aparato de Golgi/metabolismo , Vacuolas/metabolismo , Wortmanina/metabolismo , Arabidopsis/efectos de los fármacos , Proteínas de Arabidopsis/metabolismo , Endosomas/efectos de los fármacos , Endosomas/metabolismo , Aparato de Golgi/efectos de los fármacos , Inhibidores de Proteínas Quinasas/metabolismo , Inhibidores de la Síntesis de la Proteína/metabolismo , Transporte de Proteínas , Red trans-Golgi/metabolismo
14.
Annu Rev Microbiol ; 72: 185-207, 2018 Sep 08.
Artículo en Inglés | MEDLINE | ID: mdl-29906204

RESUMEN

The ribosome is a major antibiotic target. Many types of inhibitors can stop cells from growing by binding at functional centers of the ribosome and interfering with its ability to synthesize proteins. These antibiotics were usually viewed as general protein synthesis inhibitors, which indiscriminately stop translation at every codon of every mRNA, preventing the ribosome from making any protein. However, at each step of the translation cycle, the ribosome interacts with multiple ligands (mRNAs, tRNA substrates, translation factors, etc.), and as a result, the properties of the translation complex vary from codon to codon and from gene to gene. Therefore, rather than being indiscriminate inhibitors, many ribosomal antibiotics impact protein synthesis in a context-specific manner. This review presents a snapshot of the growing body of evidence that some, and possibly most, ribosome-targeting antibiotics manifest site specificity of action, which is modulated by the nature of the nascent protein, the mRNA, or the tRNAs.


Asunto(s)
Antibacterianos/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Ribosómico/metabolismo , Proteínas Ribosómicas/metabolismo , Ribosomas/efectos de los fármacos , Antibacterianos/metabolismo , Unión Proteica , Inhibidores de la Síntesis de la Proteína/metabolismo
15.
Sci Rep ; 7(1): 11022, 2017 09 08.
Artículo en Inglés | MEDLINE | ID: mdl-28887466

RESUMEN

Here we describe an HPLC-based method to quantify bacterial housekeeping nucleotides and the signaling messengers ppGpp and pppGpp. We have replicated and tested several previously reported HPLC-based approaches and assembled a method that can process 50 samples in three days, thus making kinetically resolved experiments feasible. The method combines cell harvesting by rapid filtration, followed by acid extraction, freeze-drying with chromatographic separation. We use a combination of C18 IPRP-HPLC (GMP unresolved and co-migrating with IMP; GDP and GTP; AMP, ADP and ATP; CTP; UTP) and SAX-HPLC in isocratic mode (ppGpp and pppGpp) with UV detection. The approach is applicable to bacteria without the requirement of metabolic labelling with 32P-labelled radioactive precursors. We applied our method to quantify nucleotide pools in Escherichia coli BW25113 K12-strain both throughout the growth curve and during acute stringent response induced by mupirocin. While ppGpp and pppGpp levels vary drastically (40- and ≥8-fold, respectively) these changes are decoupled from the quotients of the housekeeping pool and guanosine and adenosine housekeeping nucleotides: NTP/NDP/NMP ratio remains stable at 6/1/0.3 during both normal batch culture growth and upon acute amino acid starvation.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Escherichia coli/química , Guanosina Pentafosfato/análisis , Guanosina Tetrafosfato/análisis , Nucleótidos/análisis , Escherichia coli/efectos de los fármacos , Escherichia coli/crecimiento & desarrollo , Mupirocina/metabolismo , Inhibidores de la Síntesis de la Proteína/metabolismo
16.
Adv Microb Physiol ; 70: 105-121, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28528646

RESUMEN

A wide range of fungicides (or antifungals) are used in agriculture and medicine, with activities against a spectrum of fungal pathogens. Unfortunately, the evolution of fungicide resistance has become a major issue. Therefore, there is an urgent need for new antifungal treatments. Certain metals have been used for decades as efficient fungicides in agriculture. However, concerns over metal toxicity have escalated over this time. Recent studies have revealed that metals like copper and chromate can impair functions required for the fidelity of protein synthesis in fungi. This occurs through different mechanisms, based on targeting of iron-sulphur cluster integrity or competition for uptake with amino acid precursors. Moreover, chromate at least acts synergistically with other agents known to target translation fidelity, like aminoglycoside antibiotics, causing dramatic and selective growth inhibition of several fungal pathogens of humans and plants. As such synergy allows the application of decreased amounts of metals for effective inhibition, it lessens concerns about nonspecific toxicity and opens new possibilities for metal applications in combinatorial fungicides targeting protein synthesis.


Asunto(s)
Cromo , Cobre , Hongos/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Antifúngicos/metabolismo , Antifúngicos/farmacología , Cromo/metabolismo , Cromo/farmacología , Cromo/toxicidad , Cobre/metabolismo , Cobre/farmacología , Cobre/toxicidad , Farmacorresistencia Fúngica/efectos de los fármacos , Hongos/metabolismo , Fungicidas Industriales/metabolismo , Fungicidas Industriales/farmacología , Humanos , Inhibidores de la Síntesis de la Proteína/metabolismo , Inhibidores de la Síntesis de la Proteína/farmacología , Inhibidores de la Síntesis de la Proteína/toxicidad , Procesamiento Postranscripcional del ARN/efectos de los fármacos
17.
Int J Antimicrob Agents ; 49(1): 53-61, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27887965

RESUMEN

Quinupristin/dalfopristin (Q/D) and ß-lactams interact positively against methicillin-resistant Staphylococcus aureus (MRSA). The effect extends to other inhibitors of protein synthesis, but not to inhibitors of polynucleotide synthesis or assembly, or to Q/D plus non-ß-lactam cell wall inhibitors. Moreover, electron microscopy studies have correlated this effect with a thickened cell wall. In this study, we sought to determine whether inhibitors of protein synthesis might produce a specific peptidoglycan muropeptide signature that would correlate with their positive ß-lactam interaction. The muropeptides of six S. aureus isolates (three methicillin-susceptible and three MRSA) were analysed using high-performance liquid chromatography and mass spectrometry. Exposure to 0.25× the minimum inhibitory concentration of inhibitors of protein synthesis consistently produced three main alterations irrespective of methicillin resistance: (i) an increase in peak 12 (a cyclic dimer of glycine-containing disaccharide-tetrapeptide); (ii) an increase in poorly resolved late-eluting materials; and (iii) a decrease in peak 1 (a disaccharide-pentapeptide). Eventually, the rate of autolysis was also decreased, supporting the structural alteration of the peptidoglycan. Other drug classes did not produce these anomalies. An increase in peak 12 was also observed in staphylococci treated with fosfomycin, which decreases expression of the native penicillin-binding protein (PBP) 2 and 4. Parallel blockage of normal PBPs with ß-lactams abolished the anomalies, indicating that they resulted from altered function of native PBPs. This underlines the potential of inhibiting both protein synthesis and transpeptidation simultaneously and suggests that such a drug combination strategy might be efficaciously exploited.


Asunto(s)
Antibacterianos/metabolismo , Sinergismo Farmacológico , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Péptidos/análisis , Peptidoglicano/química , Inhibidores de la Síntesis de la Proteína/metabolismo , Pared Celular/química , Cromatografía Líquida de Alta Presión , Espectrometría de Masas , Pruebas de Sensibilidad Microbiana , beta-Lactamas/metabolismo
18.
Appl Microbiol Biotechnol ; 100(20): 8843-53, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27568380

RESUMEN

Studies have shown that external stress induces biofilm formation, but the underlying details are not clearly understood. This study investigates the changes in cell surface properties leading to increase in biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa in the presence of streptomycin. Bacterial attachment in the presence and absence of streptomycin was quantified by fluorescence spectroscopy. In addition, cell surface charge and contact angle were measured and the free energy barrier for attachment was modeled using extended Derjaguin-Landau-Verwey-Overbeek (xDLVO) theory. Peptides from bacterial cell surface were shaved by protease treatment and identified with ultra-performance liquid chromatography (UPLC)-QTOF and a homology search program SPIDER. Biofilm formation increased significantly in the presence of streptomycin (10 mg/L) in the culture. Bacterial cell surface charge reduced, and hydrophobicity increased leading to a net decrease in the free energy barrier for attachment. Extracellular matrix-binding protein was positively regulated in S. aureus under stress, indicating stronger interaction between bacterial cells and solid surface. In addition, several other proteins including biofilm regulatory proteins, multidrug efflux pumps, transporters, signaling proteins, and virulence factors were differentially expressed on bacterial cell surface, which is indicative of a strong stress response by bacteria to streptomycin treatment.


Asunto(s)
Antibacterianos/metabolismo , Biopelículas/crecimiento & desarrollo , Inhibidores de la Síntesis de la Proteína/metabolismo , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Estreptomicina/metabolismo , Propiedades de Superficie/efectos de los fármacos , Adhesión Bacteriana/efectos de los fármacos , Proteínas Bacterianas/análisis , Perfilación de la Expresión Génica , Proteínas de la Membrana/análisis , Pseudomonas aeruginosa/fisiología , Staphylococcus aureus/fisiología
19.
Toxicol Lett ; 258: 11-19, 2016 Sep 06.
Artículo en Inglés | MEDLINE | ID: mdl-27298272

RESUMEN

The plant-derived toxins ricin and abrin, operate by site-specific depurination of ribosomes, which in turn leads to protein synthesis arrest. The clinical manifestation following pulmonary exposure to these toxins is that of a severe lung inflammation and respiratory insufficiency. Deciphering the pathways mediating between the catalytic activity and the developing lung inflammation, requires a quantitative appreciation of the catalytic activity of the toxins, in-vivo. In the present study, we monitored truncated cDNA molecules which are formed by reverse transcription when a depurinated 28S rRNA serves as template. We found that maximal depurination after intranasal exposure of mice to 2LD50 ricin was reached 48h, where nearly 40% of the ribosomes have been depurinated and that depurination can be halted by post-exposure administration of anti-ricin antibodies. We next demonstrated that the effect of ricin intoxication on different cell types populating the lungs differs greatly, and that outstandingly high levels of damage (80% depurination), were observed in particular for pulmonary epithelial cells. Finally, we found that the magnitude of depurination induced by the related plant-derived toxin abrin, was significantly lower in comparison to ricin, and can be attributed mostly to reduced depurination of pulmonary epithelial cells by abrin. This study provides for the first time vital information regarding the scope and timing of the catalytic performance of ricin and abrin in the lungs of intact animals.


Asunto(s)
Citotoxinas/toxicidad , Pulmón/efectos de los fármacos , Intoxicación/metabolismo , Inhibidores de la Síntesis de la Proteína/toxicidad , Mucosa Respiratoria/efectos de los fármacos , Ribosomas/efectos de los fármacos , Ricina/toxicidad , Abrina/administración & dosificación , Abrina/aislamiento & purificación , Abrina/metabolismo , Abrina/toxicidad , Abrus/enzimología , Administración Intranasal , Animales , Antitoxinas/uso terapéutico , Citotoxinas/administración & dosificación , Citotoxinas/antagonistas & inhibidores , Citotoxinas/metabolismo , ADN Complementario/metabolismo , Femenino , Citometría de Flujo , Dosificación Letal Mediana , Pulmón/metabolismo , Pulmón/patología , Ratones , Neumonía/etiología , Neumonía/prevención & control , Intoxicación/tratamiento farmacológico , Intoxicación/patología , Intoxicación/fisiopatología , Inhibidores de la Síntesis de la Proteína/administración & dosificación , Inhibidores de la Síntesis de la Proteína/química , Inhibidores de la Síntesis de la Proteína/metabolismo , Purinas/metabolismo , ARN Ribosómico 28S/metabolismo , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/prevención & control , Mucosa Respiratoria/metabolismo , Mucosa Respiratoria/patología , Ribosomas/enzimología , Ribosomas/metabolismo , Ricina/administración & dosificación , Ricina/antagonistas & inhibidores , Ricina/metabolismo , Ricinus/enzimología
20.
Oncotarget ; 7(22): 33220-8, 2016 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-27121208

RESUMEN

Neuroblastomas constitute a major cause of cancer-related deaths in young children. In recent years, a number of translation-inhibiting enzymes have been evaluated for killing neuroblastoma cells. Here we investigated the potential vulnerability of human neuroblastoma cells to protease activity derived from botulinum neurotoxin type C. We show that following retinoic acid treatment, human neuroblastoma cells, SiMa and SH-SY5Y, acquire a neuronal phenotype evidenced by axonal growth and expression of neuronal markers. Botulinum neurotoxin type C which cleaves neuron-specific SNAP25 and syntaxin1 caused apoptotic death only in differentiated neuroblastoma cells. Direct comparison of translation-inhibiting enzymes and the type C botulinum protease revealed one order higher cytotoxic potency of the latter suggesting a novel neuroblastoma-targeting pathway. Our mechanistic insights revealed that loss of ubiquitous SNAP23 due to differentiation coupled to SNAP25 cleavage due to botulinum activity may underlie the apoptotic death of human neuroblastoma cells.


Asunto(s)
Apoptosis , Toxinas Botulínicas/biosíntesis , Diferenciación Celular , Terapia Genética/métodos , Neuroblastoma/terapia , Toxinas Botulínicas/genética , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Humanos , Neuroblastoma/enzimología , Neuroblastoma/genética , Neuroblastoma/patología , Fenotipo , Inhibidores de la Síntesis de la Proteína/metabolismo , Proteínas Qb-SNARE/metabolismo , Proteínas Qc-SNARE/metabolismo , Transducción de Señal , Proteína 25 Asociada a Sinaptosomas/metabolismo , Sintaxina 1/metabolismo , Transducción Genética , Tretinoina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA